Infection clinical trials
22 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
- Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty
- The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
- EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
- TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
- Biomarkers in Infection
- Inflammatory and Infectious Diseases of the Nervous System
- Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
- Diagnosis and Management of Inflammatory and Infectious Diseases
- Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
- Exactech Shoulder Post Market Clinical Follow-up Study
- IV Ensure in Patients Receiving OPAT
- Augmented Reality For MRI-Guided Interventions
- Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans
- Comparison of Sepsis Prediction Algorithms
- EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 3)
- Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
- Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems
- Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
- Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.